Raput Tablet 10 mg (Rabeprazole)

Adult dose

1. Short-term treatment of gastric ulcer: The usual dose of lafutidine is 10mg orally twice daily, in the morning and at bedtime. In clinical trials with treatment for up to 8 weeks, most ulcers healed within 8 weeks, although healing time may occasionally vary among patients. 2. Short-term treatment of duodenal ulcer: The usual dose of lafutidine is 10mg orally twice daily, in the morning and at bedtime. In clinical trials with treatment for up to 6 weeks, most ulcers healed within 6 weeks, although healing time may occasionally vary among patients. 3. Improvement of gastric mucosal lesions in acute gastritis and chronic gastritis: The usual dose of lafutidine is 10mg orally once daily at bedtime. In clinical trials with treatment for up to 2 weeks, most lesions healed within 2 weeks, although healing time may occasionally vary among patients. 4. Antibiotic combination therapy for patients with peptic ulcer infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Preanesthetic medication: The usual dose is 10mg of lafutidine per administration, given orally twice (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer lafutidine 10mg orally twice daily.

This drug should not be used in patients with allergies to certain ingredients. As it contains lactose, caution is needed for patients with lactose intolerance or certain genetic metabolic disorders. Patients with allergies to soy oil, beans, peanuts, etc. should also avoid this medication. Patients who have experienced drug allergic reactions in the past, those with reduced liver or kidney function, patients undergoing dialysis, and the elderly should use this medication with caution. Additionally, patients with dyslipidemia or metabolic diseases such as pancreatitis also require caution. This drug can rarely cause serious allergic reactions, liver dysfunction, blood cell reduction, etc., so if any unusual symptoms occur, stop using it immediately and consult a physician. Mild side effects such as headache, dyspepsia, abdominal pain, nausea, and constipation have also been reported, so patients should pay attention to their symptoms. Patients suspected of having malignant tumors must undergo thorough examinations before taking this medication, and if diagnosed with malignant gastric cancer, treatment should be discontinued. Monitor the treatment course closely, and if there is no efficacy, it is advisable to switch to another treatment method. The elderly may have reduced physical function, so the dosage and administration interval should be adjusted, and their condition closely monitored. Patients undergoing dialysis may have increased blood drug concentration, so treatment should be initiated cautiously with a low dose. Pregnant women should only take it when necessary under a physician's guidance, and breastfeeding women are recommended to avoid taking it as it may be excreted in breast milk. The safety for children has not been thoroughly established, so caution is required for use. Finally, this drug should be stored out of the reach of children, and transferring it to a different container from the original can lead to a decrease in the drug's quality and increase the risk of misuse.

Shock

This medication may be sensitive to air or moisture, so it should be kept in a tightly closed container. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius room temperature. This storage condition helps maintain the drug's efficacy for a longer period.

Appearance

White round film-coated tablets

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle